Skip to main content
Premium Trial:

Request an Annual Quote

BGI Offer for Complete Genomics Extended Until March 1

NEW YORK (GenomeWeb News) – BGI said after the close of the market on Friday it has again extended its cash tender offer for Complete Genomics.

The $118 million deal is now set to expire at midnight ET on March 1. The offer has been pushed back several times and most recently was to expire at midnight Feb. 22.

The depositary for the offer indicated that as of the close of business on Friday, more than 30.8 million shares, or 87 percent, of Complete Genomics' common stock had been validly tendered and not withdrawn.

BGI did not provide a reason for the extension but previously said that it is awaiting approval from China's Ministry of Commerce and the State Administration of Foreign Exchange.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.